NBY

Q: What is the price of NovaBay Pharmaceuticals Inc (NBY) today?

The current price of NovaBay Pharmaceuticals Inc (NBY) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 5.64 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does NovaBay Pharmaceuticals Inc (NBY) pay dividends?

NovaBay Pharmaceuticals Inc (NBY) did not pay dividends over the past year.

NovaBay Pharmaceuticals Inc

Price

$ -

return (12m)

0.00%

p/e

-5.39

p/bv

0.23

DIVIDEND YIELD

330.58%

NBY price

NovaBay Pharmaceuticals Inc

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NBY

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals NBY

review the fundamentals of NovaBay Pharmaceuticals Inc shares

P/E

-5.39

Sector: -1.95 Industry: 0.52

P/S (PSR)

3.41

Sector: 1.97 Industry: 2.45

P/BV

0.23

Sector: 2.12 Industry: 2.37

DIVIDEND YIELD (DY)

330.58%

Sector: - Industry: -

ROA

-3.25%

Sector: -28.58% Industry: -27.25%

ROE

-4.21%

Sector: -34.90% Industry: -37.73%

ROIC

Sector: -439.49% Industry: -94.70%

NET MARGIN

-63.26%

Sector: -30.31% Industry: -32.17%

GROSS MARGIN

-0.87%

Sector: 44.90% Industry: 49.66%

OPERATING MARGIN

-58.93%

Sector: -25.22% Industry: -28.69%

EV/EBITDA

-7.40

Sector: -0.24 Industry: 0.86

EV/EBIT

-7.19

Sector: -1.89 Industry: -0.33

PRICE-TO-ASSETS

0.18

Sector: 1.16 Industry: 1.29

BVPS

5.34

Sector: 3.76 Industry: 4.82

EPS

-0.22

Sector: -0.92 Industry: -0.75

EQUITY-TO-ASSETS RATIO

0.77

Sector: 0.43 Industry: 0.45

LIABILITIES / ASSETS

0.23

Sector: 0.46 Industry: 0.51

CAGR REVENUE 5 YEARS

0.87%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-2.29%

Sector: - Industry: -

Fundamentals NBY

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.12	32.50	81.02%	0.57%	$ 1.01 T	34.99%
ISRG	48.98	8.29	16.93%	0.00%	$ 145.93 B	28.15%
SNY	7.23	1.29	17.79%	3.99%	$ 108.01 B	14.75%
TMO	25.50	3.35	13.15%	0.38%	$ 174.59 B	15.15%
NVS	21.59	7.51	34.77%	2.03%	$ 292.21 B	23.92%
ABT	23.76	2.83	11.91%	2.85%	$ 149.12 B	13.91%
MDT	21.42	0.00	-%	3.54%	$ 102.82 B	13.20%
GSK	13.49	4.56	33.77%	3.33%	$ 105.82 B	17.79%
CVS	44.27	1.67	3.78%	2.61%	$ 129.80 B	0.72%
BSX	19.67	2.71	13.78%	0.00%	$ 70.13 B	17.29%
TMDX	14.42	5.02	34.80%	0.00%	$ 2.48 B	27.04%
IDXX	40.97	28.84	70.38%	0.00%	$ 44.87 B	24.63%
HCA	12.77	-29.12	-228.14%	0.76%	$ 86.73 B	8.89%
RMD	18.53	4.34	23.41%	0.93%	$ 28.16 B	27.44%
DHR	34.57	2.41	6.97%	0.76%	$ 127.51 B	14.89%
INMD	9.72	1.28	13.18%	0.00%	$ 847.35 M	23.27%
PHG	22.29	1.91	8.56%	3.83%	$ 25.19 B	5.50%
SYK	35.73	5.19	14.52%	1.11%	$ 119.24 B	13.21%
CI	12.12	1.87	15.39%	2.04%	$ 78.74 B	2.34%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NBY Historical Dividends

current DY: 330.58%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	09/29/2025	09/29/2025	4,00000000
Dividends	09/29/2025	09/29/2025	4,00000000

ABOUT NovaBay Pharmaceuticals Inc

NovaBay Pharmaceuticals Inc

Average Investor10 user rating

4.0 (6 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

NovaBay Pharmaceuticals Inc (United States) is listed on the Nasdaq and has a market capitalization of $31.48 Millions, with shareholders equity totaling $138.83 Millions.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, NovaBay Pharmaceuticals Inc reported $9.24 Millions in revenue, generating net income of $-5.84 Millions.

Key financial metrics include a P/E ratio of -5.39, a price-to-book (P/B) ratio of 0.23, and a trailing twelve-month dividend yield of 330.58%.

The company trades under the ticker NBY.

Market cap

$ 31.48 Millions

Net worth

$ 138.83 Millions

$ 138,825,000.00

Assets

$ 179.74 Millions

$ 179,743,000.00

Total Shares Outstanding

26.02 Millions

26,015,000

Average Daily Trading Volume

$ 554.45 Thousand

$ 554,450.00

Sector

Health

Industry

Pharmaceutical Products

NBY

NBY revenue and profits

Financial Results NBY

DRAG THE FRAME TO SEE MORE DATA

NBY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

CVS - CVS Health

$ 101.96 56,65% (12M)

P/E

44.27

2.61%

ROE

3.78%

P/BV

1.67

CI - Cigna

$ 298.00 --3,58% (12M)

P/E

12.12

2.04%

ROE

15.39%

P/BV

1.87

CNC - Centene

$ 65.19 18,06% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$ 379.22 64,11% (12M)

P/E

40.27

0.93%

ROE

6.06%

P/BV

2.44

SNY - Sanofi

$ 44.25 --7,40% (12M)

P/E

7.23

3.99%

ROE

17.79%

P/BV

1.29

LLY - Eli Lilly

$ 1,133.00 41,29% (12M)

P/E

40.12

0.57%

ROE

81.02%

P/BV

32.50

HCA - HCA Healthcare

$ 387.18 5,20% (12M)

P/E

12.77

0.76%

ROE

-228.14%

P/BV

-29.12

NVS - Novartis

$ 153.07 30,64% (12M)

P/E

21.59

2.03%

ROE

34.77%

P/BV

7.51

CVS - CVS Health

$ 101.96 56,65% (12 M)

P/L

44.27

2.61%

ROE

3.78%

P/VP

1.67

CI - Cigna

$ 298.00 --3,58% (12 M)

P/L

12.12

2.04%

ROE

15.39%

P/VP

1.87

CNC - Centene

$ 65.19 18,06% (12 M)

P/L

-4.98

0.00%

ROE

-29.93%

P/VP

1.49

HUM - Humana

$ 379.22 64,11% (12 M)

P/L

40.27

0.93%

ROE

6.06%

P/VP

2.44

SNY - Sanofi

$ 44.25 --7,40% (12 M)

P/L

7.23

3.99%

ROE

17.79%

P/VP

1.29

LLY - Eli Lilly

$ 1,133.00 41,29% (12 M)

P/L

40.12

0.57%

ROE

81.02%

P/VP

32.50

HCA - HCA Healthcare

$ 387.18 5,20% (12 M)

P/L

12.77

0.76%

ROE

-228.14%

P/VP

-29.12

NVS - Novartis

$ 153.07 30,64% (12 M)

P/L

21.59

2.03%

ROE

34.77%

P/VP

7.51

Frequently Asked Questions

What is the price of NovaBay Pharmaceuticals Inc (NBY) today?

The current price of NovaBay Pharmaceuticals Inc (NBY) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 5.64 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does NovaBay Pharmaceuticals Inc (NBY) pay dividends?

NovaBay Pharmaceuticals Inc (NBY) did not pay dividends over the past year.

Is NovaBay Pharmaceuticals Inc (NBY) a good investment?

NovaBay Pharmaceuticals Inc (NBY) is currently trading at $ 0.00 with a P/E ratio of -5.39. This represents a -2,120% premium compared to its historical average P/E. Over the past year, the stock has gained 0 and paid $ 0.00 in dividends, resulting in a dividend yield of 330.58%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy NovaBay Pharmaceuticals Inc (NBY) stock?

You can buy NovaBay Pharmaceuticals Inc (NBY) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol NBY and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of NovaBay Pharmaceuticals Inc (NBY) yield today?

Over the past month, NovaBay Pharmaceuticals Inc (NBY) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 1.60 per share in dividends, resulting in a dividend yield of 330.58%.

If you were to purchase 100 shares of NovaBay Pharmaceuticals Inc (NBY) today at the current price of $ 0.00 your total investment would be $ 0.00.

Based on historical performance, the investment would have grown to approximately:

$ 0.00 after 1 year
$ 0.00 after 5 years
$ 0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

NBY

NovaBay Pharmaceuticals Inc

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NBY

review the fundamentals of NovaBay Pharmaceuticals Inc shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 330.58%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT NovaBay Pharmaceuticals Inc

NovaBay Pharmaceuticals Inc

United States

- year

-

Financial Results NBY

NBY cash flow

Asset, Revenue and Profit Growth - NBY

NBY balance sheet

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

Frequently Asked Questions